1. Home
  2. SSM vs GOVX Comparison

SSM vs GOVX Comparison

Compare SSM & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sono Group N.V. Ordinary Shares

SSM

Sono Group N.V. Ordinary Shares

N/A

Current Price

$3.90

Market Cap

6.4M

Sector

N/A

ML Signal

N/A

Logo GeoVax Labs Inc.

GOVX

GeoVax Labs Inc.

HOLD

Current Price

$1.19

Market Cap

6.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSM
GOVX
Founded
2016
2001
Country
Germany
United States
Employees
23
19
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4M
6.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SSM
GOVX
Price
$3.90
$1.19
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
6.8K
524.2K
Earning Date
05-20-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1,462,987.20
N/A
Revenue Next Year
$48.49
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.42
$0.12
52 Week High
$10.54
$4.40

Technical Indicators

Market Signals
Indicator
SSM
GOVX
Relative Strength Index (RSI) 42.51 40.60
Support Level $3.61 $1.17
Resistance Level $4.49 $2.00
Average True Range (ATR) 0.49 0.10
MACD 0.01 0.01
Stochastic Oscillator 20.00 16.67

Price Performance

Historical Comparison
SSM
GOVX

About SSM Sono Group N.V. Ordinary Shares

Sono Group NV is engaged in the field of solar-powered electric mobility. With its proprietary solar technology, the company is able to integrate solar panels into a vehicle's bodywork, using energy captured from the sun to charge the vehicle's battery. The group is engaged in the design and development of its own first solar electric vehicle, the Sion. Its Products and services include Complete Solar Solutions, Solar Charge Controllers, Solar Modules, Data Services, and Engineering Services. The company's single business segment manages the financing, research and development, and product commercialization.

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.

Share on Social Networks: